| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $12.63B | $11.34B | $10.01B |
| YoY Revenue Growth % | +11.4% | +13.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.82B | $2.70B | $2.17B |
| Operating Margin % | 22.4% | 23.9% | 21.7% |
| Net Income (GAAP) | $2.39B | $2.29B | $1.84B |
| EBITDA (Normalized) | $2.84B | $2.72B | $2.54B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $3.11B | $2.65B | $2.05B |
| Capital Expenditures (CapEx) | $20.0M | $22.0M | $450.6M |
| Free Cash Flow (FCF) | $3.09B | $2.63B | $1.60B |
| FCF Margin % | 24.5% | 23.2% | 16.0% |
| Return on Invested Capital (ROIC %) | 8.7% | 9.2% | 18.5% |
| Cash & Short-Term Equivalents | $1.43B | $983.0M | — |
| Total Debt (Short + Long Term) | $11.29B | $10.15B | $3.59B |
| Total Stockholders' Equity | $15.91B | $13.94B | $7.37B |